Trial
NCT05114837
Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Lymphoma Leukemia
Intervention
allogeneic CAR19 regulatory T cells (CAR19-tTreg)
Why stopped
replaced with a new IND and protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-19